These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25826851)

  • 1. [Leprosy and human rights: trends in Japan and in the world].
    Yokota Y
    Nihon Hansenbyo Gakkai Zasshi; 2014 Dec; 83(3):15-9. PubMed ID: 25826851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death and Survival of Patients with Hansen's Disease in Colonial Korea.
    Kim JH
    Uisahak; 2019 Aug; 28(2):469-508. PubMed ID: 31495820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A 50-year history of new drugs in Japan: the developments of antileprosy drugs and their epidemiological aspects].
    Ozawa H; Maruyama Y
    Yakushigaku Zasshi; 2002; 37(1):76-83. PubMed ID: 12412600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Modern History of 'Imperial Medicine' Surrounding Hansen's Disease: Strategies to Manage Public Opinion in Modern Japanese Media.
    Seo G
    Uisahak; 2017 Dec; 26(3):417-454. PubMed ID: 29311533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on the measures against Hansen's disease during the Colonial Korea].
    Lu HM
    Nihon Ishigaku Zasshi; 2003 Jul; 49(2):223-61. PubMed ID: 14518471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peculiar history to formation of 'Freely recuperate zone' in the National Sanatorium Kuryu Rakusen-en, Gunma, Japan (relation between the 'Old Yunosawa-ward' and 'Freely recuperate zone' in the National Sanatorium Kuryu Rakusen-en)].
    Kitahara M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):249-59. PubMed ID: 21941831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The history of Yunosawa village and the leprosy policy in Japan: a study of a free medical-treatment area for leprosy patients.
    Mori S
    Hist Sci (Tokyo); 2004 Nov; 14(2):137-53. PubMed ID: 16060064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiatives to address leprosy as a human rights issue through the mandate of UN Special Rapporteur: Achievements and challenges.
    Nanri T
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010201. PubMed ID: 35299228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hansen's disease recoverers as agents of change: a case study in Japan.
    Hosoda M
    Lepr Rev; 2010 Mar; 81(1):5-16. PubMed ID: 20496565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons From the Wrong Isolation Policy Violating Human Rights for Leprosy in Japan.
    Horikoshi Y; Toizumi M
    Pediatr Infect Dis J; 2023 Jun; 42(6):e212-e216. PubMed ID: 36916867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leprosy and medicine II--progress and establishment of an absolute isolation policy].
    Mori S; Ishii N
    Nihon Hansenbyo Gakkai Zasshi; 2007 Feb; 76(1):29-65. PubMed ID: 17315749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy prevention law and healthcare professionals in Japan.
    Aoki Y
    Int Hist Nurs J; 2002; 7(2):68-74. PubMed ID: 12243103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leprosy and medicine I--proposal of an isolation policy and its background].
    Mori S; Ishii N
    Nihon Hansenbyo Gakkai Zasshi; 2006 Feb; 75(1):3-22. PubMed ID: 16562495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of promin in Japan and global elimination of Hansen's disease].
    Yuasa Y
    Yakugaku Zasshi; 1997 Nov; 117(10-11):957-62. PubMed ID: 9414603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The history of Yunosawa village and the policy of leprosy of Japan III].
    Mori S; Kato S; Yokoyama H; Tanaka U; Kaneda S
    Nihon Hansenbyo Gakkai Zasshi; 2003 Aug; 72(3):217-37. PubMed ID: 14598631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leprosy as a neglected disease and its stigma in the northeast of Brazil.
    Silva CA; Albuquerque VL; Antunes MF
    Indian J Lepr; 2014; 86(2):53-9. PubMed ID: 25591279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy care. The impact of multiple drug therapy.
    Philip W
    Afr Health; 1994 May; 16(4):21-4. PubMed ID: 12287669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key sources of strength and resilience for persons receiving services for Hansen's disease (leprosy) in Porto Velho, Brazil: What can we learn for service development?
    Van't Noordende AT; Bakirtzief da Silva Pereira Z; Kuipers P
    Int Health; 2021 Dec; 13(6):527-535. PubMed ID: 33547894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steps towards eliminating Hansen's disease stigma.
    Deps P; Delboni L; Oliveira TIA; Collin SM; Andrade MA; Maciel ELN
    Int Health; 2023 Dec; 15(Supplement_3):iii7-iii9. PubMed ID: 38118154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [History of Hansen's disease control policy in the United States].
    Sato H; Frantz JE
    Nihon Hansenbyo Gakkai Zasshi; 2005 Feb; 74(1):23-41. PubMed ID: 15745062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.